메뉴 건너뛰기
Primary Care Companion to the Journal of Clinical Psychiatry
Volumn 12, Issue 2, 2010, Pages
Addition of bupropion SR to varenicline alleviated depression and suicidal ideation: A case report
Author keywords

[No Author keywords available]
Indexed keywords

AMFEBUTAMONE; PAROXETINE; VARENICLINE;
EID: 78650545409     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.09l00800blu     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 33745614361 scopus 로고    scopus 로고
    • Varenicline Phase 3 Study Group: Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial
    • PubMed. doi:10.1001/jama.296.1.47
    • Gonzales D, Rennard SI, Nides M, et al. Varenicline Phase 3 Study Group: Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296:47-55. PubMed doi:10.1001/jama.296.1.47
    • (2006) JAMA , vol.296 , pp. 47-55
    • Gonzales, D.1    Rennard, S.I.2    Nides, M.3
  • 2
    • 33745611449 scopus 로고    scopus 로고
    • Varenicline Phase 3 Study Group: Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial
    • PubMed. doi:10.1001/jama.296.1.56
    • Jorenby DE, Hays JT, Rigotti NA, et al. Varenicline Phase 3 Study Group: efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296:56-63. PubMed doi:10.1001/jama.296.1.56
    • (2006) JAMA , vol.296 , pp. 56-63
    • Jorenby, D.E.1    Hays, J.T.2    Rigotti, N.A.3
  • 3
    • 36849027596 scopus 로고    scopus 로고
    • Varenicline in the routine treatment of tobacco dependence: A pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness
    • PubMed. doi:10.1111/j.1360-0443.2007.02083.x
    • Stapleton JA, Watson L, Spirling LI, et al. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction. 2008;103:146-154. PubMed doi:10.1111/j.1360-0443.2007.02083.x
    • (2008) Addiction , vol.103 , pp. 146-154
    • Stapleton, J.A.1    Watson, L.2    Spirling, L.I.3
  • 4
    • 40749136302 scopus 로고    scopus 로고
    • FDA warns of adverse events linked to smoking cessation drug and antiepileptics
    • PubMed. doi:10.1001/jama.299.10.1121
    • Kuehn BM. FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA. 2008;299:1121-1122. PubMed doi:10.1001/jama.299.10.1121
    • (2008) JAMA , vol.299 , pp. 1121-1122
    • Kuehn, B.M.1
  • 5
    • 0025923219 scopus 로고
    • The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire
    • doi:10.1111/j.1360-0443.1991.tb01879.x PubMed
    • Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x PubMed
    • (1991) Br J Addict , vol.86 , Issue.9 , pp. 1119-1127
    • Heatherton, T.F.1    Kozlowski, L.T.2    Frecker, R.C.3
  • 6
    • 84965520932 scopus 로고
    • The CES-D scale: A self-report depression scale for research in the general population
    • doi:10.1177/014662167700100306
    • Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.1177/014662167700100306
    • (1977) Appl Psychol Meas , vol.1 , Issue.3 , pp. 385-401
    • Radloff, L.S.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.